Dose-dense chemotherapy improves clinical outcomes in breast cancer

By  

Inpharma, Vol. 1, Iss. 1392, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Review of Dose-intense Platinum and/or Paclitaxel Containing Chemotherapy in Advanced and Recurrent Epithelial Ovarian Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3741-3753

Bentham Science Publishers

Access to resources Recommend Favorite

A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors

By Chang Susan M.   Kuhn John G.   Ian Robins H.   Clifford Schold S.   Spence Alexander M.   Berger Mitchel S.   Mehta Minesh P.   Pollack Ian   Gilbert Mark   Prados Michael D.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 429-433

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Trial of Dose-Dense Docetaxel and Doxorubicin with or without Sargramostim in Patients with Metastatic Breast Cancer

By Montero Alberto   Booser Daniel   Esparza-Guerra Laura   Murray James   Rosales Marguerite   Hortobagyi Gabriel   Valero Vicente  

Drugs in R&D, Vol. 6, Iss. 5, 2005-01 ,pp. : 299-305

Adis International

Access to resources Recommend Favorite

A Phase I Study of Dose-Dense Topotecan Given Upfront to Standard Therapy in Patients with Small Cell Lung Cancer

By Garst Jennifer  

Clinical Drug Investigation, Vol. 26, Iss. 5, 2006-01 ,pp. : 257-266

Adis International

Access to resources Recommend Favorite